Novotech Acquires US-based Regulatory Consulting Firm CBR International
January 9, 2023
Novotech, an Asia-Pacific–focused clinical research organization (CRO), has acquired US-based regulatory and drug development consultancy CBR International. The acquisition strengthens Novotech's US FDA regulatory, scientific and clinical development capabilities to better support biotech and pharma clients across the US, Europe and Asia-Pacific.
- Buyers
- Novotech
- Targets
- CBR International
- Industry
- Healthcare Services
- Location
- Colorado, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Novotech to Acquire Agilex Biolabs from Healius to Expand Australian Bioanalytical Services
September 25, 2026
Healthcare Services
Novotech entered into an agreement to acquire Agilex Biolabs, an Adelaide-based Australian specialist bioanalytical laboratory business, from a wholly owned subsidiary of Healius. The deal is intended to expand Novotech’s laboratory capabilities in Australia and strengthen integrated clinical research and laboratory services for biotechnology and pharmaceutical clinical trial sponsors. Financial terms were not disclosed, and closing remains subject to customary regulatory conditions.
-
Biosynth Acquires Cambridge Research Biochemicals (CRB)
May 9, 2023
Biotechnology
Biosynth, a Switzerland-based supplier of critical materials to the life science industry, has acquired Cambridge Research Biochemicals (CRB), a UK-based independent producer of custom peptides and antibody tools. The acquisition expands Biosynth's peptide and antibody capabilities in Europe, adding expertise in complex peptide chemistry, fluorescent dye labelling and custom antibody generation to its existing operations.
-
Novotech Acquires EastHORN Clinical Services
January 10, 2023
Healthcare Services
Novotech, the Asia-Pacific biotech specialist CRO, has acquired European contract research organization EastHORN Clinical Services to strengthen its global operations and European infrastructure. EastHORN — established in 2004 with more than 250 employees and operations across 30+ European countries — will retain its brand while being integrated into Novotech's systems to offer clients expanded in‑country expertise and access to Novotech's Asia‑Pacific and US capabilities.
-
Everest Clinical Research Acquires Brightech International
December 2, 2022
Healthcare Services
Everest Clinical Research, a PE-backed full-service contract research organization, has acquired Brightech International, a specialist CRO focused on biostatistics, statistical programming, and clinical data management. The deal strengthens Everest's biometrics capabilities and global footprint, complementing its therapeutic strengths in Oncology, CNS, and Immunology.
-
Novo Integrated Sciences Acquires Clinical Consultants International LLC
March 23, 2022
Healthcare Services
Novo Integrated Sciences (NASDAQ: NVOS) has acquired Clinical Consultants International LLC (CCI) in an all-stock transaction, completing the purchase in April 2022. CCI, a Boca Raton–based global healthcare consulting firm led by Dr. Joseph M. Chalil, will see Dr. Chalil appointed Chief Medical Officer of Novo and President of Novomerica Health Group to expand Novo's healthcare capabilities and market entry services.
-
Lambda Therapeutic Research Acquires Novum Pharmaceutical Research Services
January 29, 2019
Healthcare Services
Lambda Therapeutic Research Ltd. has acquired U.S.-based Contract Research Organization Novum Pharmaceutical Research Services in a private transaction, with Novum becoming a wholly owned subsidiary. The deal (terms undisclosed) expands Lambda's footprint and capabilities in the U.S., adding Novum's facilities in Pittsburgh, Las Vegas, Fargo and Houston and complementary clinical, bioanalytical and regulatory services.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.